INTERMOUNTAIN HEALTH CARE, INC.

Higher-Dose, Two-Session Vaginal Brachytherapy Proves Effective for Endometrial Cancer Treatment

- A randomized clinical trial led by Huntsman Cancer Institute demonstrates that two sessions of high-dose vaginal brachytherapy are as effective as standard multiple low-dose treatments for endometrial cancer. - The SAVE trial findings offer a more convenient treatment option for patients, particularly benefiting those in rural areas who face challenges accessing multiple treatment sessions. - Research shows comparable short-term outcomes and minimal acute toxicities between the new two-session approach and traditional 3-5 session treatment protocol.